国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Ayurveda Treatment of Brahmi Vati in Generalized Anxiety Disorder

Helen Davies

Generalized Anxiety Disorder (GAD) is the foremost common anxiety disorder. GAD has tall comorbidities and it can influence social, proficient and individual life. Ayurvedic medicine, Brahmi vati is investigated for the possible role in management of GAD and is compared to Manasmitra vataka. A randomized double blind controlled trial, with total 56 patients meeting the DSM V criteria of GAD between 20–60 years of age and either sex participated within the study. Members were randomly partitioned into two groups, Brahmi group received capsule B. vati 500 mg and Manasmitra group received capsule M. vataka 500 mg thrice a day with water for 45 days. Assessments were conducted through different clinical parameters such as Hamilton Anxiety Rating Scale. Blood variables including Hemoglobin, Erythrocyte Sedimentation Rate (ESR), Liver Function Test (LFT) and serum creatinine were assessed before and after the study. Evaluations amid intervention were conducted on every 15th day. B. vati and M. vataka were effective, secure and comparable within the management of GAD.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。